JP Morgan Chase
NEO icon

JP Morgan Chase’s NeoGenomics NEO Stock Holding History

JP Morgan Chase’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-45,000
Closed -$860K – 5788
2019
Q3 		$860K Buy
+45,000
New +$1.06M ﹤0.01% 3915

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

JP Morgan Chase's NEO Position: Q2 2026 in Review

JP Morgan Chase reduced its NeoGenomics (NEO) stake by 4.1% in Q2 2026, selling an estimated $237K and leaving 581,091 shares worth $8.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2970.

JP Morgan Chase first reported a position in NEO in Q2 2013 and has held it in 40 quarters since. The position peaked at $20.9M in Q1 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • JP Morgan Chase held 581,091 shares of NeoGenomics worth $8.36M as of Q2 2026.
  • JP Morgan Chase sold 24,572 NeoGenomics shares in Q2 2026, an estimated $237K.
  • NeoGenomics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2970 holding.
  • JP Morgan Chase first reported a position in NeoGenomics in Q2 2013 and has held it in 40 quarters since.
  • JP Morgan Chase's NeoGenomics position peaked at $20.9M in Q1 2023.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.